Palliativmedizin in der Pneumologie

Zusammenfassung

Die palliativmedizinische Versorgung sollte Bestandteil der Pneumologie sein, da erstens viele pneumologische Krankheitsbilder – neben den thorakalen Tumoren – in ihrem Verlauf palliativmedizinischer Betreuung bedürfen und zweitens die Dyspnoe auch als Symptom fortgeschrittener, primär extrapulmonaler Erkrankungen der Expertise des Pneumologen bedarf. In dieser Arbeit werden die häufigsten Symptome fortgeschrittener pneumologischer Erkrankungen sowie ihre Behandlung dargestellt. Daneben werden die Versorgungsstrukturen in Deutschland dargestellt.

Abstract

Palliative care should be part of respiratory medicine for two reasons: First, many respiratory diseases – besides thoracic tumours – need palliative care in the late stages of the disease. Second, dyspnoea is a common symptom in advanced, primary extrapulmonary diseases and the knowledge of respiratory specialists can be beneficial in the treatment of this symptom. In this paper we describe frequent symptoms of advanced pulmonary diseases and their treatment. Moreover, we focus on the structure of palliative care in Germany.

Literatur

• 1 Lanken P N, Terry P B, Delisser H M. et al . An official American Thoracic Society clinical policy statement: palliative care for patients with respiratory diseases and critical illnesses.  Am J Respir Crit Care Med. 2008;  177 912-927
• 2 Nava S, Sturani C, Hartl S. et al . End-of-life decision-making in respiratory intermediate care units: a European survey.  Eur Respir J. 2007;  30 156-164
• 3 Gregor A, Thomson C S, Brewster D H. et al . Management and survival of patients with lung cancer in Scotland diagnosed in 1995: results of a national population based study.  Thorax. 2001;  56 212-217
• 4 Husebo S ;. Palliativmedizin. Heidelberg; Springer 2006
• 5 Scano G, Stendardi L, Grazzini M. Understanding dyspnoea by its language.  Eur Resp J. 2005;  25 380-385
• 6 Bruera E, Sweeney C, Willey J. et al . A randomized controlled trial of supplemental oxygen versus air in cancer patients with dyspnea.  Palliative Medicine. 2003;  17 659-663
• 7 Bausewein C, Booth S, Gysels M. et al . Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases.  Cochrane Database Syst Rev. 2008;  January 1 CD005623
• 8 Jennings A L, Davies A N, Higgins J P. et al . Opioids for the palliation of breathlessness in terminal illness.  Cochrane Database Syst Rev. 2001;  CD002066
• 9 Ripamonti C, Fulfaro F, Bruera E. Dyspnoea in patients with advanced cancer: incidence, causes and treatments.  Cancer Treat Rev. 1998;  24 69-80
• 10 Abernethy A P, Uronis H E, Wheeler J L. et al . Pharmacological management of breathlessness in advanced disease.  Progress in Palliative Care. 2008;  16 15-20
• 11 Bausewein C, Rémi C, Twycross R. et al .Arzneimitteltherapie in der Palliativmedizin. München, Jena; Urban und Fischer 2005: 133-206
• 12 Flieder M, Jansen J P. Praxishandbuch Palliativpflege und Schmerzmanagement. Merching; Forum 2007
• 13 Husebo S, Klaschik E. Palliativmedizin. Heidelberg; Springer 2006: 203-307
• 14 Aulbert E, Nauck F, Radbruch L. Lehrbuch der Palliativmedizin. Stuttgart; Schattauer 2007: 148-269
• 15 Minton O, Richardson A, Sharpe M. et al . A systematic review and meta-analysis of the pharmacological treatment of cancer-related fatigue.  J Natl Cancer Inst. 2008;  100(16) 1155-1166
• 16 Morrow G R, Jean-Pierre P, Roscoe J A. et al . A phase III randomized, placebo-controlled, double-blind trial of a eugeroic agent in 642 cancer patients reporting fatigue during chemotherapy: a URCC CCOP study (abstract).  J Clin Oncol. 2008;  26 504s
• 17 Henke M, Laszig R, Rube C. et al . Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial.  Lancet. 2003;  362 1255-1260
• 18 Thorsen L, Skovlund E, Stromme S B. et al . : Effectiveness of physical activity on cardiorespiratory fitness and health-related quality of life in young and middle-aged cancer patients shortly after chemotherapy.  J Clin Oncol. 2005;  23 2378-2388
• 19 Magnussen H, Kirsten A M, Köhler D. et al . Leitlinien zur Langzeit-Sauerstofftherapie.  Pneumologie. 2008;  62 748-756
• 20 Windisch W, Criée C P. Lebensqualität bei Patienten mit häuslicher Beatmung.  Pneumologie. 2006;  60 539-546
• 21 Windisch W. Quality of life in home mechanical ventilation study group. Impact of home mechanical ventilation on health-related quality of life.  Eur Respir J. 2008;  32 1328-1336
• 22 Garrod R, Mikelsons C, Paul E A. et al . Randomized controlled trial of domiciliary noninvasive positive pressure ventilation and physical training in severe chronic obstructive pulmonary disease.  Am J Respir Crit Care Med. 2000;  162 1335-1341
• 23 Leger P, Bedicam J M, Cornette A. et al . Nasal intermittent positive pressure ventilation. Long-term follow-up in patients with severe chronic respiratory insufficiency.  Chest. 1994;  105 100-105
• 24 Schols A MWJ, Broekhuizen R, Weling-Scheepers C A. et al . Body composition and mortality in chronic obstructive disease.  Am J Clin Nutr. 2005;  82 53-59
• 25 Schols A MWJ. Pulmonary cachexia.  Inter J Cardiol. 2002;  85 101-110
• 26 Anker S D, John M, Pedersen P U. et al . ESPEN Guidelines on Enteral Nutrition: Cardiology and Pulmonology.  Clin Nutr. 2006;  25 311-316
• 27 Ferreira I, Brooks D, Lacasse Y. et al . Nutritional supplementation for stable chronic obstructive pulmonary disease.  Cochrane Database Syst Rev. 2005;  CD000998
• 28 Posselt H G, Smaczny C, Stern M. et al .Leitlinie Mukoviszidose (Cystische Fibrose): Ernährung und exokrine Pankreasinsuffizienz. http://www.awmf-online.de; Stand: 19. 10. 2005
• 29 Cox C E, Carson S S, Holmes G M. et al . Increase in tracheostomy for prolonged mechanical ventilation in North Carolina, 1993 – 2002.  Crit Care Med. 2004;  32 2219-2226
• 30 MacIntyre N R, Epstein S K, Carson S. et al . National association for medical direction of respiratory Care. Management of patients requiring prolonged mechanical ventilation: report of a NAMDRC consensus conference.  Chest. 2005;  128 3937-3954
• 31 Schönhofer B, Berndt C, Achtzehn U. et al . Weaning from mechanical ventilation.  Dtsch Med Wochenschr. 2008;  133 700-704
• 32 Schönhofer B, Euteneuer S, Nava S. et al . Survival of mechanically ventilated patients admitted to a specialised weaning centre.  Intensive Care Med. 2002;  28 908-916
• 33 Ankrom M, Zelesnick L, Barofsky 3rd I. et al. Elective discontinuation of life-sustaining mechanical ventilation on a chronic ventilator unit.  J Am Geriatr Soc. 2001;  491 549-554
• 34 Roeder N, Klaschik E, Cremer M. et al . DRGs in der Palliativmedizin: Ist die palliativmedizinische Begleitung Schwerstkranker pauschalierbar?.  Das Krankenhaus. 2002;  12 1000-1004